Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Jardiance
Generic name / active ingredient
empagliflozin
Dosage-form class
Empagliflozin oral film-coated tablets: 10 mg and 25 mg; each displayed as an exact 30-tablet blister-card carton (3 blister cards × 10 tablets)
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Check JARDIANCE, the generic name empagliflozin, “25 mg”, oral-tablet form and target market together. The 25 mg on this package is the illustrated product strength, not an answer to how many tablets any person should take.
  • Terms such as diabetes, heart failure or chronic kidney disease cannot be used to conclude that this pack is suitable for a particular person. Suitability, timing, a strength change or stopping all require the individual clinical context, prescription and current label in the target market.
  • If diuretics, insulin or other glucose-lowering products are also used, or questions arise around illness, unusual eating or drinking, or surgery, bring the complete medicine list to the prescribing team or pharmacist. Do not add, reduce, make up or replace doses from a webpage or package alone.
  • The image and text are only a checking starting point. Packaging can differ by market, label update or repackaging; a photograph cannot establish authenticity or current approval status.

Reviewed presentation examples — compare every field

  • 10 mg per tablet; 30-tablet carton (3 blister cards × 10 tablets)NDC 0597-0152-37
  • 25 mg per tablet; 30-tablet carton (3 blister cards × 10 tablets)NDC 0597-0153-37

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image